Pioglitazone treatment restores in vivo muscle oxidative capacity in a rat model of diabetes. (Q30848657)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25200673%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

title

Pioglitazone treatment restores in vivo muscle oxidative capacity in a rat model of diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25200673%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25200673%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Sander M. Houten

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25200673%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Klaas Nicolay

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25200673%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Jeanine J Prompers

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25200673%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

B Wessels

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25200673%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

N M A van den Broek

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25200673%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

publication date

6 October 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25200673%20AND%20SRC:MED&resulttype=core&format=json

Diabetes, Obesity and Metabolism

16 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25200673%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25200673%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25200673%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

52-60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25200673%20AND%20SRC:MED&resulttype=core&format=json

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

16 February 2020

cites work

1 reference

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

21 January 2018

1 reference

Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo

21 January 2018

1 reference

Thiazolidinediones upregulate fatty acid uptake and oxidation in adipose tissue of diabetic patients

21 January 2018

1 reference

Recent findings concerning thiazolidinediones in the treatment of diabetes

21 January 2018

1 reference

Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

21 January 2018

1 reference

Effects of pioglitazone on intramyocellular fat metabolism in patients with type 2 diabetes mellitus

21 January 2018

1 reference

Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study.

21 January 2018

1 reference

Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents.

21 January 2018

1 reference

Intramyocellular lipid and insulin resistance: a longitudinal in vivo 1H-spectroscopic study in Zucker diabetic fatty rats

21 January 2018

1 reference

Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes

21 January 2018

1 reference

Intramyocellular lipid content in type 2 diabetes patients compared with overweight sedentary men and highly trained endurance athletes.

21 January 2018

1 reference

Lipid-induced insulin resistance: unravelling the mechanism

21 January 2018

1 reference

Mitochondrial dysfunction and type 2 diabetes

21 January 2018

1 reference

Is mitochondrial dysfunction a cause of insulin resistance?

21 January 2018

1 reference

Is skeletal muscle mitochondrial dysfunction a cause or an indirect consequence of insulin resistance in humans?

21 January 2018

1 reference

The role of mitochondria in the pathogenesis of type 2 diabetes

21 January 2018

1 reference

Excess Lipid Availability Increases Mitochondrial Fatty Acid Oxidative Capacity in Muscle

21 January 2018

1 reference

High-fat diets cause insulin resistance despite an increase in muscle mitochondria

21 January 2018

1 reference

Increased mitochondrial content rescues in vivo muscle oxidative capacity in long-term high-fat-diet-fed rats.

21 January 2018

1 reference

Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance

21 January 2018

1 reference

Lipid-induced mitochondrial stress and insulin action in muscle

21 January 2018

1 reference

Linking mitochondrial bioenergetics to insulin resistance via redox biology

21 January 2018

1 reference

Pioglitazone improves insulin sensitivity through reduction in muscle lipid and redistribution of lipid into adipose tissue.

21 January 2018

1 reference

Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions?

21 January 2018

1 reference

Pioglitazone leads to an inactivation and disassembly of complex I of the mitochondrial respiratory chain

21 January 2018

1 reference

Opposite effects of pioglitazone and rosiglitazone on mitochondrial respiration in skeletal muscle of patients with type 2 diabetes.

21 January 2018

1 reference

Pioglitazone stimulates AMP-activated protein kinase signalling and increases the expression of genes involved in adiponectin signalling, mitochondrial function and fat oxidation in human skeletal muscle in vivo: a randomised trial

21 January 2018

1 reference

Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1α and PPARβ/δ gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus

21 January 2018

1 reference

Role of adiponectin in human skeletal muscle bioenergetics

21 January 2018

1 reference

Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome

21 January 2018

1 reference

Pioglitazone acutely reduces energy metabolism and insulin secretion in rats

21 January 2018

1 reference

PGC-1alpha integrates insulin signaling, mitochondrial regulation, and bioenergetic function in skeletal muscle

21 January 2018

1 reference

The dual PPARalpha/gamma agonist, ragaglitazar, improves insulin sensitivity and metabolic profile equally with pioglitazone in diabetic and dietary obese ZDF rats.

21 January 2018

1 reference

Capacity of oxidative phosphorylation in human skeletal muscle: new perspectives of mitochondrial physiology.

21 January 2018

1 reference

Characterization of carnitine and fatty acid metabolism in the long-chain acyl-CoA dehydrogenase-deficient mouse

21 January 2018

1 reference

Increased intramyocellular lipid content but normal skeletal muscle mitochondrial oxidative capacity throughout the pathogenesis of type 2 diabetes

21 January 2018

1 reference

In vivo postprandial lipid partitioning in liver and skeletal muscle in prediabetic and diabetic rats.

21 January 2018

1 reference

MITOCHONDRIA: investigation of in vivo muscle mitochondrial function by 31P magnetic resonance spectroscopy

21 January 2018

1 reference

Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control

21 January 2018

1 reference

Relationship between acid-soluble carnitine and coenzyme A pools in vivo

21 January 2018

1 reference

Uncoupling to survive? The role of mitochondrial inefficiency in ageing

21 January 2018

1 reference

A discordance in rosiglitazone mediated insulin sensitization and skeletal muscle mitochondrial content/activity in Type 2 diabetes mellitus

21 January 2018

1 reference

Regulation of PGC-1α, a nodal regulator of mitochondrial biogenesis

21 January 2018

1 reference

The insulin-sensitizing effect of rosiglitazone in type 2 diabetes mellitus patients does not require improved in vivo muscle mitochondrial function

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/DOM.12388

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25200673%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25200673%20AND%20SRC:MED&resulttype=core&format=json